You are here

Home

Clinical Trials: Kidney Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, May 5, 2022 - 12:00
Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease
Condition:   Chronic Kidney Diseases
Intervention:   Drug: Allogeneic adipose-derived mesenchymal stem cells (MSC)
Sponsor:   LaTonya J. Hickson
Not yet recruiting
Posted: Friday, March 18, 2022 - 12:00
A Study of Renal Autologous Cell Therapy (REACT®) in Participants With Type 2 Diabetes and Chronic Kidney Disease
Conditions:   T2DM (Type 2 Diabetes Mellitus);   CKD (Chronic Kidney Disease)
Intervention:   Biological: Renal Autologous Cell Therapy (REACT®)
Sponsors:   Prokidney;   Iqvia Pty Ltd
Not yet recruiting
Posted: Friday, October 29, 2021 - 12:00
A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Conditions:   Type 2 Diabetes Mellitus;   Chronic Kidney Diseases
Intervention:   Biological: Renal Autologous Cell Therapy
Sponsors:   Prokidney;   Iqvia Pty Ltd;   PPD
Not yet recruiting
Posted: Wednesday, October 27, 2021 - 12:00
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
Conditions:   Chronic Pancreatitis;   Mesenchymal Stem Cells
Interventions:   Biological: Bone marrow-derived mesenchymal stem cells;   Other: Placebo
Sponsors:   Medical University of South Carolina;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting
Posted: Monday, September 13, 2021 - 12:00
Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease
Conditions:   Chronic Kidney Disease Stage 3B;   Chronic Kidney Disease stage4
Intervention:   Biological: Cellgram-CKD
Sponsor:   Pharmicell Co., Ltd.
Not yet recruiting
Posted: Monday, August 30, 2021 - 12:00
Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)
Condition:   Osteoarthritis, Knee
Interventions:   Drug: Bone marrow mesenchymal stem cells;   Drug: hyaluronic acid
Sponsors:   Taiwan Bio Therapeutics Co., Ltd.;   A2 Healthcare Taiwan Corporation
Not yet recruiting
Posted: Tuesday, August 24, 2021 - 12:00
STUDY OF RENAL AUTOLOGOUS CELL THERAPY (REACT) IN SUBJECTS WITH TYPE 1 or 2 DIABETES AND CHRONIC KIDNEY DISEASE (REGEN-007)
Condition:   Chronic Kidney Diseases
Intervention:   Drug: Renal Autologous Cell Therapy (REACT)
Sponsor:   Prokidney
Recruiting
Posted: Tuesday, August 24, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD
Condition:   Chronic Kidney Diseases
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Thursday, May 6, 2021 - 12:00
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)
Conditions:   Ciliopathies;   Nephronophthisis;   Senior-Loken Syndrome;   Joubert Syndrome;   Jeune Syndrome;   Bardet-Biedl Syndrome
Interventions:   Other: Blood sample;   Other: Urine sample
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Posted: Tuesday, March 9, 2021 - 12:00
lncRNAs as a Biomarker to Assess the Therapeutic Impact of Oral Absorbent ± Probiotics in CKD Patients With PAD
Conditions:   CKD;   PAD
Intervention:   Dietary Supplement: Active bamboo charcoal± probiotics
Sponsor:   National Taiwan University Hospital
Recruiting

Pages